We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
451
Pacific Biosciences
PACB
$432M
$2.4M 0.03%
331,355
+44,000
+15% +$318K
UGI icon
452
UGI
UGI
$7.96B
$2.36M 0.03%
42,539
-20,322
-32% -$1.11M
TEL icon
453
TE Connectivity
TEL
$61.9B
$2.34M 0.03%
29
+1
+4% +$81
NTAP icon
454
NetApp
NTAP
$34B
$2.33M 0.03%
33,619
+637
+2% +$41.1K
IQV icon
455
IQVIA
IQV
$40.3B
$2.33M 0.03%
16,167
-2,493
-13% -$332K
JD icon
456
JD.com
JD
$42.7B
$2.33M 0.03%
77,150
+9,050
+13% +$230K
MLAB icon
457
Mesa Laboratories
MLAB
$557M
$2.32M 0.03%
10,067
+2,642
+36% +$597K
MFC icon
458
Manulife Financial
MFC
$74.1B
$2.3M 0.03%
135,849
+1,460
+1% +$23.7K
APH icon
459
Amphenol
APH
$178B
$2.29M 0.03%
97,096
-2,812
-3% -$62.9K
ORLY icon
460
O'Reilly Automotive
ORLY
$75.7B
$2.29M 0.03%
88,575
+7,110
+9% +$172K
CHRW icon
461
C.H. Robinson
CHRW
$20.2B
$2.28M 0.03%
26,209
+1,854
+8% +$163K
AZO icon
462
AutoZone
AZO
$50.8B
$2.27M 0.03%
2,215
+75
+4% +$67.3K
NLY icon
463
Annaly Capital Management
NLY
$17.3B
$2.27M 0.03%
56,729
-1,461
-3% -$59.6K
HAL icon
464
Halliburton
HAL
$26.2B
$2.25M 0.03%
76,918
-52,111
-40% -$1.57M
CNQ icon
465
Canadian Natural Resources
CNQ
$92.8B
$2.25M 0.03%
166,903
+3,057
+2% +$40.6K
DOC icon
466
Healthpeak Properties
DOC
$15.8B
$2.25M 0.03%
60,759
+19,859
+49% +$605K
BXP icon
467
Boston Properties
BXP
$11.1B
$2.23M 0.03%
16,652
+1,471
+10% +$189K
SJR
468
DELISTED
Shaw Communications Inc.
SJR
$2.21M 0.03%
106,136
+44,931
+73% +$910K
HSBC icon
469
HSBC
HSBC
$355B
$2.19M 0.03%
55
+20
+57% +$806
CAG icon
470
Conagra Brands
CAG
$7.4B
$2.17M 0.03%
78,111
+35,409
+83% +$812K
CAJ
471
DELISTED
Canon, Inc.
CAJ
$2.16M 0.03%
20,509
-77
-0.4% -$2.21K
STT icon
472
State Street
STT
$50.1B
$2.16M 0.03%
32,780
+1,617
+5% +$112K
ACHN
473
DELISTED
Achillion Pharmaceuticals
ACHN
$2.15M 0.03%
725,000
– –
MTD icon
474
Mettler-Toledo International
MTD
$28B
$2.14M 0.03%
2,965
-857
-22% -$557K
RCI icon
475
Rogers Communications
RCI
$18.6B
$2.13M 0.03%
39,666
+4,182
+12% +$225K
17 18
19
20 21

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.